Tuberculosis News and Research

Latest Tuberculosis News and Research

Study identifies six markers in the breath that could become stress-detector

The perennial stress-buster - a deep breath - could become stress-detector, Loughborough University researchers claim. According to a new pilot study, published today, 28 February, in IOP Publishing's Journal of Breath Research, there are six markers in the breath that could be candidates for use as indicators of stress.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Post-2015 development agenda should focus on accelerating progress made against HIV, TB, malaria

"In a little more than two years, the world will hit an important target: the date by which the Millennium Development Goals [MDGs] are meant to be achieved," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.

28 Feb 2013

Research shows many cancers can be prevented with healthy lifestyle choices

Each year more individuals worldwide die from cancer than malaria, tuberculosis and HIV combined. With research showing that many cancers can be prevented with healthy lifestyle choices, Seattle Cancer Care Alliance is working to raise awareness of preventive tactics in honor of National Cancer Prevention Month.

27 Feb 2013

Examining global efforts against Buruli ulcer

"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.

27 Feb 2013

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 210 of its "Global Fund Observer."

26 Feb 2013

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeutics, announced today that the first patient has been dosed in a Phase 1b clinical study of AVX-470, an oral anti-TNF antibody, for the treatment of ulcerative colitis.

25 Feb 2013

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

"An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research," the Los Angeles Times reports.

23 Feb 2013

With financial commitment, Obama can add 'end of AIDS' to his legacy

"In his State of the Union address, President Obama stated with confidence that the promise of an AIDS-free generation is within our reach," Archbishop Emeritus of Capetown Desmond Tutu writes in a USA Today opinion piece, adding, "We currently possess the power to begin to end a global pandemic that has killed 25 million and infected another 34 million."

22 Feb 2013

Scientists uncover atomic structure of dermcidin

An international team of scientists has discovered how an important natural antibiotic called dermcidin, produced by our skin when we sweat, is a highly efficient tool to fight tuberculosis germs and other dangerous bugs.

22 Feb 2013

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.

21 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Outstanding U.S. and Canadian scientists to receive Sloan Research Fellowships for 2013

The Alfred P. Sloan Foundation is pleased to announce the selection of 126 outstanding U.S. and Canadian researchers as recipients of Sloan Research Fellowships for 2013.

20 Feb 2013

AIDS-free generation is within reach but only with fully-funded Global Fund

In the Huffington Post's "Impact" blog, ACTION Director Kolleen Bouchane highlights President Barack Obama's mention of global development and global health in Tuesday's State of the Union address.

16 Feb 2013

Having launched PEPFAR, George W. Bush is greatest humanitarian to serve U.S. presidency

In a post in Foreign Policy's "Democracy Lab" blog, Christian Caryl, a senior fellow at the Legatum Institute and the blog's editor, asks, "Which United States president will go down in history as the greatest humanitarian to have served in the office?" He writes, "I'd suggest that there's one president whose contribution dwarfs all the others" -- George W. Bush.

16 Feb 2013

China's new first lady has ability to influence public health activism

In an opinion piece published on contextChina, Robert O'Brien, a PhD candidate in international relations at the University of Oxford, examines how China's new first lady, acclaimed folk singer Peng Liyuan, might influence public health activism in the country.

15 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

Xpert diagnosis of TB and its drug resistant strains

The use of a novel, diagnostic test called Xpert is both sensitive and specific in detecting tuberculosis and rifampicin resistance, report US researchers.

14 Feb 2013

The Atlantic examines 'paradigm shift' in global health response

"The world has an 'historic opportunity' to contain and end three of humanity's deadliest scourges by focusing on their 'hot zones,' according to Mark Dybul, the newly appointed director of the Geneva-based Global Fund to Fight AIDS, Tuberculosis, and Malaria," the Atlantic reports in an article examining a "paradigm shift" in the global health response.

14 Feb 2013

AIDS.gov blog examines Global Fund's future

"During January's World Economic Forum, international leaders welcomed former U.S. Global AIDS Coordinator Mark Dybul as the new head of the Global Fund to Fight AIDS, Tuberculosis and Malaria," Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in the AIDS.gov blog.

13 Feb 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

Study identifies six markers in the breath that could become stress-detector

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Post-2015 development agenda should focus on accelerating progress made against HIV, TB, malaria

Research shows many cancers can be prevented with healthy lifestyle choices

Examining global efforts against Buruli ulcer

Aidspan publishes new issue of 'Global Fund Observer'

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

With financial commitment, Obama can add 'end of AIDS' to his legacy

Scientists uncover atomic structure of dermcidin

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Outstanding U.S. and Canadian scientists to receive Sloan Research Fellowships for 2013

AIDS-free generation is within reach but only with fully-funded Global Fund

Having launched PEPFAR, George W. Bush is greatest humanitarian to serve U.S. presidency

China's new first lady has ability to influence public health activism

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

Xpert diagnosis of TB and its drug resistant strains

The Atlantic examines 'paradigm shift' in global health response

AIDS.gov blog examines Global Fund's future

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in